1,424 results on '"Kreek, Mary Jeanne"'
Search Results
2. Impact of OPRM1 (Mu-opioid Receptor Gene) A112G Polymorphism on Dual Oxycodone and Cocaine Self-administration Behavior in a Mouse Model
3. Contributors
4. Addictions
5. Neurobiological Mechanisms in Substance Use
6. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders
7. Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist
8. Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond
9. Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders
10. Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis
11. Blockade of alcohol excessive and “relapse” drinking in male mice by pharmacological cryptochrome (CRY) activation
12. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts
13. Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J mice
14. Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent
15. Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors
16. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice
17. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat
18. Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions
19. Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist
20. OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics
21. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders
22. Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features
23. Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury
24. Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction
25. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence
26. Single-Nucleotide Polymorphism in the Human Mu opioid Receptor Gene Alters β -Endorphin Binding and Activity: Possible Implications for Opiate Addiction
27. Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice
28. Opioid receptors in GtoPdb v.2023.1
29. Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration
30. Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry
31. Blockade of alcohol escalation and “relapse” drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice
32. Alterations of expression of inflammation/immune-related genes in the dorsal and ventral striatum of adult C57BL/6J mice following chronic oxycodone self-administration: a RNA sequencing study
33. “Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats”
34. Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence
35. V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice
36. Endocrinological Effects of Drugs of Abuse
37. Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations
38. Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
39. Can a rapid measure of self‐exposure to drugs of abuse provide dimensional information on depression comorbidity?
40. Association of Polymorphisms of the Mu Opioid Receptor Gene with the Severity of HIV Infection and Response to HIV Treatment
41. Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls
42. Common liability to addiction and “gateway hypothesis”: Theoretical, empirical and evolutionary perspective
43. Semisynthetic neoclerodanes as kappa opioid receptor probes
44. Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression
45. Sex and chronic stress alter the distribution of glutamate receptors within rat hippocampal CA3 pyramidal cells following oxycodone conditioned place preference
46. Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.
47. List of Contributors
48. The Hypothalamic–Pituitary–Adrenal Axis and Related Brain Stress-Response Systems and Heroin
49. Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions
50. The Widely Available Hallucinogenic Plant Salvia divinorum and Its Main Component, Salvinorin A
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.